During the past decade, ZGT Almelo conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ZGT Almelo" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Elisabeth Brouwer" with 1 trials sponsored and "University Medical Center Groningen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ZGT Almelo" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Cisbio Bioassays" with 1 trials as a collaborator and "Dutch Arthritis Foundation Reuma Nederland" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ZGT Almelo" are "Heart Failure" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials), "Abdominal Pain" (1 trials) and "Benign Prostatic Hyperplasia" (1 trials). Many other conditions were trialed in "ZGT Almelo" in a lesser frequency.

Most popular intervention types in "ZGT Almelo" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Tirzepatide" (2 trials), "Leflunomide 20 mg" (1 trials) and "Photoselective Vaporization of the Prostate" (1 trials). Other intervention names were less common.

The vast majority of trials in "ZGT Almelo" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ZGT Almelo". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ZGT Almelo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ZGT Almelo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".